Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Rifaximin

Rifaximin

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Rifaximin

25 trials tracked of Rifaximin: 13 in phase 3 or 4 and 1 with published results. The most-cited published study has 22 citations.

25Trials tracked
13Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 11 Phase 2 5 Phase 1 1 Other / NA 6
  1. Phase 4 Rifaximin Therapy in Chronic Kidney Disease Completed · 22 cited
  2. Phase 4 The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy Completed
  3. Phase 3 Treating Bacterial Overgrowth in Parkinson's Disease Completed
  4. Phase 3 Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer Completed
  5. Phase 3 A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy Completed
  6. Phase 3 Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy Completed
Show 19 more trials
  1. Phase 3 Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth Completed
  2. Phase 3 A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) Completed
  3. Phase 3 Rifaximin for Prevention of Travellers' Diarrhea Completed
  4. Phase 3 Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea Completed
  5. Phase 3 Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) Completed
  6. Phase 3 Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori Infection Completed
  7. Phase 3 Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS) Completed
  8. Phase 2 Efficacy and Safety of Rifaximin With NAC in IBS-D Completed
  9. Phase 2 Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea Completed
  10. Phase 2 Rifaximin as a Modulator of Microbial Translocation and Immune Activation Completed
  11. Phase 2 MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) Completed
  12. Phase 2 Rifaximin for Chronic Immune Activation in People With HIV Completed
  13. Phase 1 Role of Methane in Glycemic Control Completed
  14. N/A Trial of Rifaximin in the Treatment of Tropical Enteropathy Completed
  15. N/A Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome Completed
  16. N/A A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans Completed
  17. N/A Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease Completed
  18. N/A Rifaximin in Minimal Hepatic Encephalopathy Completed
  19. N/A Gulf War Digestive Health Study Completed

Showing the 25 most-cited and recently-updated of 25 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.